Abstract
A retrospective review of the psychiatric records of nine patients with posttraumatic stress disorder (PTSD) was conducted to determine the efficacy of cyproheptadine in relieving nightmares. The treatment dose was 4 to 12 mg at bedtime. The response varied from complete remission to a decrease in the intensity and frequency of nightmares.
MeSH terms
-
Adult
-
Cyproheptadine / therapeutic use*
-
Dreams / drug effects*
-
Drug Administration Schedule
-
Drug Therapy, Combination
-
Evaluation Studies as Topic
-
Female
-
Humans
-
Male
-
Middle Aged
-
Retrospective Studies
-
Serotonin Antagonists / therapeutic use*
-
Stress Disorders, Post-Traumatic / drug therapy*
-
Treatment Outcome
Substances
-
Serotonin Antagonists
-
Cyproheptadine